mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.09 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.09 |
0.1 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.1 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.1 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.1 |